Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI
NM_004333.6(BRAF):c.1781A>T (p.Asp594Val)	BRAF	D594V	Cardio-facio-cutaneous syndrome|Rasopathy|Neoplasm of the large intestine|Melanoma	Pathogenic(Last reviewed: May 18, 2020)	reviewed by expert panel	VCV000375946	7	140453154	7	140753354	375946	362825	rs121913338	NC_000007.14:140753353:T:A
NM_004333.6(BRAF):c.1390G>A (p.Gly464Arg)	BRAF	G464R	Cardio-facio-cutaneous syndrome|Rasopathy|not provided|Melanoma	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372572	7	140481418	7	140781618	372572	359643	rs121913349	NC_000007.14:140781617:C:T
NM_004333.6(BRAF):c.1796C>G (p.Thr599Arg)	BRAF	T599R	Cardiofaciocutaneous syndrome 1|not provided|Rasopathy	Pathogenic(Last reviewed: Mar 24, 2020)	reviewed by expert panel	VCV000280033	7	140453139	7	140753339	280033	264307	rs121913375	NC_000007.14:140753338:G:C
NM_004333.6(BRAF):c.1785T>A (p.Phe595Leu)	BRAF	F595L	Rasopathy|not provided|Melanoma	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180789	7	140453150	7	140753350	180789	179094	rs121913341	NC_000007.14:140753349:A:T
NM_004333.6(BRAF):c.739T>C (p.Phe247Leu)	BRAF	F247L	Noonan syndrome|Noonan syndrome and Noonan-related syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000180784	7	140501333	7	140801533	180784	179102	rs397516903	NC_000007.14:140801532:A:G
NM_001374258.1(BRAF):c.1575G>T (p.Leu525Phe)	BRAF	L485F, L451F, L488F, L525F, L448F, L397F, L433F, L463F	Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Feb 27, 2020)	reviewed by expert panel	VCV000177844	7	140477853	7	140778053	177844	174043	rs180177036	NC_000007.14:140778052:C:A
NM_001374258.1(BRAF):c.1905T>G (p.Phe635Leu)	BRAF	F595L, F573L, F598L, F543L, F635L, F507L, F558L, F561L	Rasopathy|Cardio-facio-cutaneous syndrome|not provided|Neoplasm|Melanoma	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000177672	7	140453150	7	140753350	177672	174042	rs121913341	NC_000007.14:140753349:A:C
NM_001374258.1(BRAF):c.2034T>G (p.Asp678Glu)	BRAF	D638E, D601E, D604E, D641E, D586E, D616E, D678E, D550E	Rasopathy|Cardio-facio-cutaneous syndrome|Noonan syndrome 1|Cardiofaciocutaneous syndrome 1|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000162797	7	140449165	7	140749365	162797	174176	rs180177042	NC_000007.14:140749364:A:C
NM_004333.6(BRAF):c.741T>G (p.Phe247Leu)	BRAF	F247L	not provided|Noonan syndrome and Noonan-related syndrome|Noonan syndrome	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000055793	7	140501331	7	140801531	55793	70449	rs397509343	NC_000007.14:140801530:A:C
NM_001374258.1(BRAF):c.722C>A (p.Thr241Lys)	BRAF	T241K, T153K, T189K, T207K, T244K	Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Jun 25, 2020)	reviewed by expert panel	VCV000044829	7	140501350	7	140801550	44829	53996	rs387906660	NC_000007.14:140801549:G:T
NM_004333.6(BRAF):c.1799T>G (p.Val600Gly)	BRAF	V600G	Rasopathy|Melanoma|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Jun 25, 2020)	reviewed by expert panel	VCV000040389	7	140453136	7	140753336	40389	48859	rs113488022	NC_000007.14:140753335:A:C
NM_004333.6(BRAF):c.1796C>T (p.Thr599Ile)	BRAF	T599I	not provided|Neoplasm|Rasopathy|Melanoma|Noonan syndrome	Pathogenic(Last reviewed: Mar 24, 2020)	reviewed by expert panel	VCV000040388	7	140453139	7	140753339	40388	48858	rs121913375	NC_000007.14:140753338:G:A
NM_001374258.1(BRAF):c.1907G>T (p.Gly636Val)	BRAF	G596V, G508V, G599V, G544V, G559V, G574V, G562V, G636V	Glioblastoma|Multiple myeloma|Transitional cell carcinoma of the bladder|Ventriculomegaly|Abnormal facial shape|Curly hair|Severe global developmental delay|Thick vermilion border|Epicanthus|Wide nasal base|Telecanthus|not provided|Rasopathy|Cardiofaciocutaneous syndrome 1|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome|Lung adenocarcinoma|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040387	7	140453148	7	140753348	40387	48857	rs397507483	NC_000007.14:140753347:C:A
NM_004333.6(BRAF):c.1502A>C (p.Glu501Ala)	BRAF	E501A	Noonan syndrome|Rasopathy|Cardiofaciocutaneous syndrome 1|not provided	Pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040373	7	140477806	7	140778006	40373	48843	rs180177039	NC_000007.14:140778005:T:G
NM_001374258.1(BRAF):c.1523T>C (p.Phe508Ser)	BRAF	F468S, F508S, F416S, F471S, F380S, F431S, F434S, F446S	not provided|Rasopathy|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Sep 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040366	7	140481405	7	140781605	40366	48836	rs397507473	NC_000007.14:140781604:A:G
NM_001374258.1(BRAF):c.1511G>T (p.Gly504Val)	BRAF	G464V, G427V, G376V, G442V, G412V, G430V, G467V, G504V	Non-small cell lung cancer|Rasopathy|Breast neoplasm|Neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000040364	7	140481417	7	140781617	40364	48834	rs121913348	NC_000007.14:140781616:C:A
NM_004333.6(BRAF):c.784C>A (p.Gln262Lys)	BRAF	Q262K	Rasopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040352	7	140501288	7	140801488	40352	48822	rs397507470	NC_000007.14:140801487:G:T
NM_001374258.1(BRAF):c.735A>T (p.Leu245Phe)	BRAF	L245F, L211F, L157F, L248F, L193F	Rasopathy|Noonan syndrome with multiple lentigines|Noonan syndrome and Noonan-related syndrome|Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040348	7	140501337	7	140801537	40348	48818	rs397507466	NC_000007.14:140801536:T:A
NM_001374258.1(BRAF):c.735A>C (p.Leu245Phe)	BRAF	L245F, L211F, L157F, L248F, L193F	Rasopathy|not provided|Noonan syndrome and Noonan-related syndrome|LEOPARD syndrome 3|Cardiofaciocutaneous syndrome 1|Noonan syndrome 1|Lung carcinoma|LEOPARD syndrome 3|Noonan syndrome 7|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040347	7	140501337	7	140801537	40347	48817	rs397507466	NC_000007.14:140801536:T:G
NM_001374258.1(BRAF):c.730A>C (p.Thr244Pro)	BRAF	T244P, T156P, T192P, T210P, T247P	Rasopathy|Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040346	7	140501342	7	140801542	40346	48816	rs397507465	NC_000007.14:140801541:T:G
NM_004333.6(BRAF):c.1593G>C (p.Trp531Cys)	BRAF	W531C	Noonan syndrome 7|Noonan syndrome 1|Rasopathy	Pathogenic(Last reviewed: Apr 4, 2014)	criteria provided, single submitter	VCV000029808	7	140476813	7	140777013	29808	38763	rs606231228	NC_000007.14:140777012:C:G
NM_001374258.1(BRAF):c.721A>C (p.Thr241Pro)	BRAF	T241P, T189P, T244P, T207P, T153P	Cardiofaciocutaneous syndrome 1|LEOPARD syndrome 3|not provided|Cardiofaciocutaneous syndrome 1|Noonan syndrome 1|Lung carcinoma|LEOPARD syndrome 3|Noonan syndrome 7|Noonan syndrome with multiple lentigines|Cardiofaciocutaneous syndrome 1|LEOPARD syndrome 3|Noonan syndrome 7|Cardio-facio-cutaneous syndrome|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000029807	7	140501351	7	140801551	29807	38762	rs387906661	NC_000007.14:140801550:T:G
NM_001374258.1(BRAF):c.722C>T (p.Thr241Met)	BRAF	T241M, T189M, T207M, T244M, T153M	Rasopathy|Noonan syndrome|Noonan syndrome 7|not provided|Cardiofaciocutaneous syndrome 1|Noonan syndrome 1|Lung carcinoma|LEOPARD syndrome 3|Noonan syndrome 7|Noonan syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000029805	7	140501350	7	140801550	29805	38760	rs387906660	NC_000007.14:140801549:G:A
NM_001374258.1(BRAF):c.1861A>G (p.Asn621Asp)	BRAF	N581D, N547D, N529D, N559D, N584D, N621D, N493D, N544D	not provided|Rasopathy|Cardiofaciocutaneous syndrome 1|Cardio-facio-cutaneous syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013979	7	140453987	7	140754187	13979	29018	rs180177040	NC_000007.14:140754186:T:C
NM_001374258.1(BRAF):c.1622A>G (p.Glu541Gly)	BRAF	E501G, E467G, E504G, E464G, E479G, E413G, E449G, E541G	Rasopathy|not provided|Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|High forehead|Low-set, posteriorly rotated ears|Webbed neck|Pulmonic stenosis (disease)|Ventricular septal defect|Neonatal respiratory distress|Wide intermamillary distance|Ventricular hypertrophy|Premature birth|Downslanted palpebral fissures	Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013978	7	140477806	7	140778006	13978	29017	rs180177039	NC_000007.14:140778005:T:C
NM_001374258.1(BRAF):c.1621G>A (p.Glu541Lys)	BRAF	E501K, E504K, E541K, E467K, E413K, E449K, E464K, E479K	not provided|Noonan syndrome|Cardio-facio-cutaneous syndrome|Rasopathy|Cardiofaciocutaneous syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013977	7	140477807	7	140778007	13977	29016	rs180177038	NC_000007.14:140778006:C:T
NM_004333.6(BRAF):c.1495A>G (p.Lys499Glu)	BRAF	K499E	Rasopathy|not provided|Cardiofaciocutaneous syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013976	7	140477813	7	140778013	13976	29015	rs180177037	NC_000007.14:140778012:T:C
NM_001374258.1(BRAF):c.1575G>C (p.Leu525Phe)	BRAF	L485F, L451F, L433F, L448F, L488F, L397F, L463F, L525F	Rasopathy|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardiofaciocutaneous syndrome 1|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Feb 28, 2020)	reviewed by expert panel	VCV000013975	7	140477853	7	140778053	13975	29014	rs180177036	NC_000007.14:140778052:C:G
NM_001374258.1(BRAF):c.1526G>A (p.Gly509Glu)	BRAF	G469E, G381E, G447E, G417E, G432E, G472E, G435E, G509E	not specified|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Rasopathy|Melanoma|Adenocarcinoma of prostate|Cardiofaciocutaneous syndrome 1|Neoplasm of the large intestine|not provided|Malignant melanoma of skin|Cardio-facio-cutaneous syndrome|Squamous cell lung carcinoma|Lung adenocarcinoma|Multiple myeloma	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013974	7	140481402	7	140781602	13974	29013	rs121913355	NC_000007.14:140781601:C:T
NM_001374258.1(BRAF):c.770A>G (p.Gln257Arg)	BRAF	Q257R, Q205R, Q223R, Q260R, Q169R	Inborn genetic diseases|not provided|Rasopathy|Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|LEOPARD syndrome 3|Noonan syndrome 7|not specified	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013973	7	140501302	7	140801502	13973	29012	rs180177035	NC_000007.14:140801501:T:C
NM_001374258.1(BRAF):c.736G>C (p.Ala246Pro)	BRAF	A246P, A158P, A194P, A212P, A249P	not provided|Noonan syndrome|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome|Rasopathy|Cardiofaciocutaneous syndrome 1	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013965	7	140501336	7	140801536	13965	29004	rs180177034	NC_000007.14:140801535:C:G
NM_001374258.1(BRAF):c.1511G>A (p.Gly504Glu)	BRAF	G464E, G427E, G442E, G504E, G412E, G467E, G376E, G430E	Neoplasm|Rasopathy|not provided|Noonan syndrome|Cardio-facio-cutaneous syndrome|Chronic lymphocytic leukemia|Cardio-facio-cutaneous syndrome|Carcinoma of colon	Pathogenic(Last reviewed: Mar 9, 2020)	reviewed by expert panel	VCV000013964	7	140481417	7	140781617	13964	29003	rs121913348	NC_000007.14:140781616:C:T
NM_005188.3(CBL):c.1111T>C (p.Tyr371His)	CBL	Y371H	Hematologic neoplasm|Rasopathy|Noonan syndrome-like disorder with juvenile myelomonocytic leukemia|not provided	Pathogenic(Last reviewed: Jan 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013811	11	119148891	11	119278181	13811	28850	rs267606706	NC_000011.10:119278180:T:C
NM_005188.3(CBL):c.1100A>C (p.Gln367Pro)	CBL	Q367P	Rasopathy|Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|not provided|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013807	11	119148880	11	119278170	13807	28846	rs267606704	NC_000011.10:119278169:A:C
NM_005343.4(HRAS):c.35_36delinsAT (p.Gly12Asp)	HRAS	G12D	Rasopathy	Pathogenic(Last reviewed: Dec 19, 2013)	criteria provided, single submitter	VCV000180854	11	534287 - 534288	11	534287 - 534288	180854	179420	rs727503094	NC_000011.10:534286:GC:AT
NM_005343.4(HRAS):c.179G>A (p.Gly60Asp)	HRAS	G60D	not provided	Pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000040436	11	533877	11	533877	40436	48906	rs730880460	NC_000011.10:533876:C:T
NM_005343.4(HRAS):c.34G>T (p.Gly12Cys)	HRAS	G12C	Rasopathy|Malignant melanoma of skin|Breast neoplasm|Glioblastoma|Bladder carcinoma|Carcinoma of esophagus|Squamous cell carcinoma of the head and neck|Myelodysplastic syndrome|not provided|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Hepatocellular carcinoma|Pancreatic adenocarcinoma|Urinary bladder cancer|Epidermal nevus|Large congenital melanocytic nevus|Follicular thyroid carcinoma|Costello syndrome|Epidermal nevus syndrome|Epidermal nevus|Uterine Carcinosarcoma|Papillary renal cell carcinoma, sporadic|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of prostate|Costello syndrome|Acute myeloid leukemia|Lung adenocarcinoma|Nevus sebaceous|Malignant neoplasm of body of uterus|Neoplasm of the thyroid gland|Nasopharyngeal Neoplasms|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Multiple myeloma	Pathogenic(Last reviewed: Nov 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012613	11	534289	11	534289	12613	27652	rs104894229	NC_000011.10:534288:C:A
NM_005343.4(HRAS):c.35G>A (p.Gly12Asp)	HRAS	G12D	not provided|Costello syndrome, severe|Costello syndrome|Breast neoplasm|Nevus sebaceous|Rasopathy|Lip and oral cavity carcinoma	Pathogenic(Last reviewed: Jun 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012612	11	534288	11	534288	12612	27651	rs104894230	NC_000011.10:534287:C:T
NM_005343.4(HRAS):c.173C>T (p.Thr58Ile)	HRAS	T58I	Costello syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012610	11	533883	11	533883	12610	27649	rs121917758	NC_000011.10:533882:G:A
NM_005343.4(HRAS):c.37G>T (p.Gly13Cys)	HRAS	G13C	Malignant melanoma of skin|Breast neoplasm|Noonan syndrome|Hepatocellular carcinoma|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Urinary bladder cancer|Epidermal nevus|Large congenital melanocytic nevus|Follicular thyroid carcinoma|Costello syndrome|Epidermal nevus syndrome|Rasopathy|Uterine cervical neoplasms|Malignant neoplasm of body of uterus|Costello syndrome|Multiple myeloma|Squamous cell lung carcinoma|not provided|Neoplasm of the thyroid gland|Adenocarcinoma of stomach|Lung adenocarcinoma|Neoplasm|Chronic lymphocytic leukemia|Acute myeloid leukemia	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012606	11	534286	11	534286	12606	27645	rs104894228	NC_000011.10:534285:C:A
NM_005343.4(HRAS):c.350A>G (p.Lys117Arg)	HRAS	K117R, S11G	not provided|Costello syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012605	11	533553	11	533553	12605	27644	rs104894227	NC_000011.10:533552:T:C
NM_005343.4(HRAS):c.38G>A (p.Gly13Asp)	HRAS	G13D	not provided|Rasopathy|Neoplasm of the large intestine|Costello syndrome	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012604	11	534285	11	534285	12604	27643	rs104894226	NC_000011.10:534284:C:T
NM_005343.4(HRAS):c.34G>A (p.Gly12Ser)	HRAS	G12S	not provided|Rasopathy|Nevus, woolly hair|Malignant melanoma of skin|Breast neoplasm|Inborn genetic diseases|Glioblastoma|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|Hepatocellular carcinoma|Squamous cell carcinoma of the head and neck|Myelodysplastic syndrome|Pancreatic adenocarcinoma|Acute myeloid leukemia|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Uterine Carcinosarcoma|Papillary renal cell carcinoma, sporadic|Uterine cervical neoplasms|Adenoid cystic carcinoma|Adenocarcinoma of prostate|Myopathy, congenital, with excess of muscle spindles|Costello syndrome|Epidermal nevus with urothelial cancer, somatic|Nevus sebaceous|Malignant neoplasm of body of uterus|Neoplasm of the thyroid gland|Ovarian Serous Cystadenocarcinoma|Nasopharyngeal Neoplasms|Adenocarcinoma of stomach|Lung adenocarcinoma|Multiple myeloma|Lip and oral cavity carcinoma	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012602	11	534289	11	534289	12602	27641	rs104894229	NC_000011.10:534288:C:T
NM_005343.4(HRAS):c.181C>A (p.Gln61Lys)	HRAS	Q61K	Lip and oral cavity carcinoma|Follicular thyroid carcinoma|Breast neoplasm|not provided|Spermatocytic seminoma|Noonan syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012601	11	533875	11	533875	12601	27640	rs28933406	NC_000011.10:533874:G:T
NM_004985.5(KRAS):c.108A>G (p.Ile36Met)	KRAS	I36M	not provided|Rasopathy|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardiofaciocutaneous syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000163768	12	25398211	12	25245277	163768	175716	rs727503109	NC_000012.12:25245276:T:C
NM_004985.5(KRAS):c.458A>G (p.Asp153Gly)	KRAS	D153G	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040465	12	25362838	12	25209904	40465	48935	rs104894360	NC_000012.12:25209903:T:C
NM_004985.5(KRAS):c.101C>T (p.Pro34Leu)	KRAS	P34L	not provided|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040454	12	25398218	12	25245284	40454	48924	rs104894366	NC_000012.12:25245283:G:A
NM_004985.5(KRAS):c.65A>G (p.Gln22Arg)	KRAS	Q22R	not provided|Cardiofaciocutaneous syndrome 2|Noonan syndrome 3|not specified|Noonan syndrome 3|Rasopathy|Noonan syndrome|Hereditary diffuse gastric cancer	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040452	12	25398254	12	25245320	40452	48922	rs727503110	NC_000012.12:25245319:T:C
NM_033360.4(KRAS):c.64C>G (p.Gln22Glu)	KRAS	Q22E	Rasopathy	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000040451	12	25398255	12	25245321	40451	48921	rs121913236	NC_000012.12:25245320:G:C
NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	KRAS	G60S	not provided|Noonan syndrome 3|Rasopathy	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012597	12	25380280	12	25227346	12597	27636	rs104894359	NC_000012.12:25227345:C:T
NM_033360.4(KRAS):c.*22C>G (p.Phe156Leu)	KRAS	F156L	Cardiofaciocutaneous syndrome 2|not provided|Rasopathy	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012595	12	25362828	12	25209894	12595	27634	rs104894362	NC_000012.12:25209893:G:C
NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	KRAS	K5N	Inborn genetic diseases|Cardiofaciocutaneous syndrome 2|Noonan syndrome|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012594	12	25398304	12	25245370	12594	27633	rs104894361	NC_000012.12:25245369:T:A
NM_004985.5(KRAS):c.40G>A (p.Val14Ile)	KRAS	V14I	Noonan syndrome 3|Noonan syndrome|Inborn genetic diseases|Endometrial carcinoma|not provided|Rasopathy|Noonan syndrome|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012589	12	25398279	12	25245345	12589	27628	rs104894365	NC_000012.12:25245344:C:T
NM_004985.5(KRAS):c.173C>T (p.Thr58Ile)	KRAS	T58I	Noonan syndrome 3|Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012588	12	25380285	12	25227351	12588	27627	rs104894364	NC_000012.12:25227350:G:A
NM_004985.5(KRAS):c.458A>T (p.Asp153Val)	KRAS	D153V	Rasopathy|Cardiofaciocutaneous syndrome 2|Cardio-facio-cutaneous syndrome|Noonan syndrome|Noonan syndrome|Noonan syndrome 3|not specified|Inborn genetic diseases|Hereditary diffuse gastric cancer|Urinary bladder cancer|Lung carcinoma|Acute myeloid leukemia|Cerebral arteriovenous malformation|Cardiofaciocutaneous syndrome 2|RAS-associated autoimmune leukoproliferative disorder|Carcinoma of pancreas|Epidermal nevus syndrome|Noonan syndrome 3|Familial cancer of breast|not provided	Pathogenic(Last reviewed: Nov 15, 2018)	reviewed by expert panel	VCV000012587	12	25362838	12	25209904	12587	27626	rs104894360	NC_000012.12:25209903:T:A
NM_004985.5(KRAS):c.178G>C (p.Gly60Arg)	KRAS	G60R	Cardiofaciocutaneous syndrome 2|Rasopathy|Inborn genetic diseases|Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012586	12	25380280	12	25227346	12586	27625	rs104894359	NC_000012.12:25227345:C:G
NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	KRAS	G12D	Non-small cell lung cancer|Juvenile myelomonocytic leukemia|Neoplasm of ovary|Neoplasm of the large intestine|Cerebral arteriovenous malformation|Rasopathy|Epidermal nevus|RAS-associated autoimmune leukoproliferative disorder|Acute myeloid leukemia|Carcinoma of pancreas|Lung carcinoma|Vascular Tumors Including Pyogenic Granuloma|Nevus sebaceous|Epidermal nevus syndrome|Primary low grade serous adenocarcinoma of ovary|not provided|Neoplasm of the thyroid gland|Neoplasm of stomach	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000012582	12	25398284	12	25245350	12582	27621	rs121913529	NC_000012.12:25245349:C:T
NM_006767.4(LZTR1):c.742G>A (p.Gly248Arg)	LZTR1	G248R	not provided|Rasopathy|Noonan syndrome 10|Schwannomatosis 2|Noonan syndrome 10|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000209088	22	21344765	22	20990476	209088	205685	rs869320686	NC_000022.11:20990475:G:A
NM_002755.3(MAP2K1):c.332T>A (p.Ile111Asn)	MAP2K1	I111N	Rasopathy|Neoplasm	Pathogenic(Last reviewed: Oct 28, 2019)	criteria provided, single submitter	VCV000376194	15	66729124	15	66436786	376194	363073	rs1057519730	NC_000015.10:66436785:T:A
NM_002755.3(MAP2K1):c.370C>T (p.Pro124Ser)	MAP2K1	P124S	Melanoma|not provided|Rasopathy|Noonan syndrome|Cardiofaciocutaneous syndrome 3|Neoplasm of the large intestine|Transitional cell carcinoma of the bladder|Malignant neoplasm of body of uterus|Malignant melanoma of skin	Pathogenic(Last reviewed: Jul 2, 2020)	reviewed by expert panel	VCV000375981	15	66729162	15	66436824	375981	362860	rs1057519732	NC_000015.10:66436823:C:T
NM_002755.3(MAP2K1):c.323G>T (p.Arg108Leu)	MAP2K1	R108L	Cardiofaciocutaneous syndrome 3|Noonan syndrome 1|Cardiofaciocutaneous syndrome 3|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 25, 2020)	reviewed by expert panel	VCV000280446	15	66729115	15	66436777	280446	264875	rs727504819	NC_000015.10:66436776:G:T
NM_002755.4(MAP2K1):c.364A>G (p.Asn122Asp)	MAP2K1	N122D	Rasopathy|Noonan syndrome|Noonan syndrome 1|Cardiofaciocutaneous syndrome 3	Pathogenic(Last reviewed: Mar 16, 2020)	reviewed by expert panel	VCV000228273	15	66729156	15	66436818	228273	230599	rs876657651	NC_000015.10:66436817:A:G
NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn)	MAP2K1	D67N	Non-small cell lung cancer|Autism spectrum disorder|Melanoma|Cardiofaciocutaneous syndrome 3|MAP2K1-related RASopathy|not provided|Rasopathy|Noonan syndrome|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000040781	15	66727483	15	66435145	40781	49251	rs727504317	NC_000015.10:66435144:G:A
NM_002755.3(MAP2K1):c.383_384delinsTT (p.Gly128Val)	MAP2K1	G128V	Rasopathy	Pathogenic(Last reviewed: Nov 4, 2012)	criteria provided, single submitter	VCV000040745	15	66729175 - 66729176	15	66436837 - 66436838	40745	49215	rs730880508	NC_000015.10:66436836:GC:TT
NM_002755.4(MAP2K1):c.383G>T (p.Gly128Val)	MAP2K1	G128V	Rasopathy|Cardiofaciocutaneous syndrome 3|not provided|Cardio-facio-cutaneous syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013352	15	66729175	15	66436837	13352	28391	rs121908596	NC_000015.10:66436836:G:T
NM_002755.4(MAP2K1):c.389A>G (p.Tyr130Cys)	MAP2K1	Y130C	Inborn genetic diseases|Hypertrophic cardiomyopathy|Cortical dysplasia|Global developmental delay|Proportionate short stature|Abnormality of the sternum|Failure to thrive|Seizures|Cardiofaciocutaneous syndrome 3|Noonan syndrome 1|Rasopathy|Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000013351	15	66729181	15	66436843	13351	28390	rs121908595	NC_000015.10:66436842:A:G
NM_002755.3(MAP2K1):c.158T>C (p.Phe53Ser)	MAP2K1	F53S	Cardiofaciocutaneous syndrome 3|Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000013350	15	66727442	15	66435104	13350	28389	rs121908594	NC_000015.10:66435103:T:C
NM_030662.3(MAP2K2):c.171T>A (p.Phe57Leu)	MAP2K2	F57L	Rasopathy	Pathogenic(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000578970	19	4117549	19	4117551	578970	574980	rs1057519910	NC_000019.10:4117550:A:T
NM_030662.4(MAP2K2):c.401A>G (p.Tyr134Cys)	MAP2K2	Y134C	Rasopathy|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000177868	19	4110556	19	4110558	177868	176031	rs727504370	NC_000019.10:4110557:T:C
NM_030662.3(MAP2K2):c.181A>G (p.Lys61Glu)	MAP2K2	K61E	Cardiofaciocutaneous syndrome 1|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040769	19	4117539	19	4117541	40769	49239	rs730880517	NC_000019.10:4117540:T:C
NM_030662.3(MAP2K2):c.383C>A (p.Pro128Gln)	MAP2K2		Cardiofaciocutaneous syndrome 4|Cardio-facio-cutaneous syndrome|not provided	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000008275	19	4110574	19	4110576	8275	23314	rs267607230	NC_000019.10:4110575:G:T
NM_030662.3(MAP2K2):c.169T>G (p.Phe57Val)	MAP2K2	F57V	Squamous cell carcinoma of the head and neck|Adenocarcinoma of stomach|Malignant melanoma of skin|Cardio-facio-cutaneous syndrome|Pancreatic adenocarcinoma|Cardiofaciocutaneous syndrome 4	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000008273	19	4117551	19	4117553	8273	23312	rs121434498	NC_000019.10:4117552:A:C
NM_030662.3(MAP2K2):c.170T>G (p.Phe57Cys)	MAP2K2		Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 4|not provided	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000008272	19	4117550	19	4117552	8272	23311	rs121434497	NC_000019.10:4117551:A:C
NM_002524.5(NRAS):c.34G>A (p.Gly12Ser)	NRAS	G12S	Multiple myeloma|Rasopathy|Melanoma|Acute myeloid leukemia|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Neoplasm of the large intestine|Noonan syndrome|Juvenile myelomonocytic leukemia|Non-small cell lung cancer|Myelodysplastic syndrome|Malignant melanoma of skin|not provided	Pathogenic(Last reviewed: Dec 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177778	1	115258748	1	114716127	177778	172332	rs121913250	NC_000001.11:114716126:C:T
NM_002524.5(NRAS):c.149C>T (p.Thr50Ile)	NRAS	T50I	Noonan syndrome 6|Noonan syndrome 1|Noonan syndrome|Rasopathy	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013902	1	115256562	1	114713941	13902	28941	rs267606921	NC_000001.11:114713940:G:A
NM_002834.4(PTPN11):c.1506_1507delinsCC (p.Gly503Arg)	PTPN11	G503R, G507R	Rasopathy	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000571101	12	112926886 - 112926887	12	112489082 - 112489083	571101	571274	rs1566186833	NC_000012.12:112489081:AG:CC
NM_002834.4(PTPN11):c.178G>C (p.Gly60Arg)	PTPN11	G60R	Rasopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372590	12	112888162	12	112450358	372590	360062	rs397507507	NC_000012.12:112450357:G:C
NM_002834.4(PTPN11):c.172A>T (p.Asn58Tyr)	PTPN11	N58Y	Rasopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181494	12	112888156	12	112450352	181494	179443	rs397507505	NC_000012.12:112450351:A:T
NM_002834.5(PTPN11):c.182A>C (p.Asp61Ala)	PTPN11	D61A, D60A	Rasopathy|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179221	12	112888166	12	112450362	179221	175539	rs121918461	NC_000012.12:112450361:A:C
NM_002834.5(PTPN11):c.214G>A (p.Ala72Thr)	PTPN11	A72T, A71T	Neuroblastoma|Rasopathy|Neoplasm of brain|Chronic lymphocytic leukemia|Acute myeloid leukemia|not provided|Noonan syndrome|Juvenile myelomonocytic leukemia|Noonan syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177754	12	112888198	12	112450394	177754	175540	rs121918453	NC_000012.12:112450393:G:A
NM_002834.5(PTPN11):c.598A>T (p.Asn200Tyr)	PTPN11	N200Y, N199Y	Noonan syndrome|Rasopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000164998	12	112892440	12	112454636	164998	175541	rs727503381	NC_000012.12:112454635:A:T
NM_002834.4(PTPN11):c.1508G>C (p.Gly503Ala)	PTPN11	G503A, G507A	Rasopathy	Pathogenic	no assertion criteria provided	VCV000162464	12	112926888	12	112489084	162464	172138	rs397507546	NC_000012.12:112489083:G:C
NM_002834.4(PTPN11):c.836A>C (p.Tyr279Ser)	PTPN11	Y279S	Rasopathy|LEOPARD syndrome 1	Pathogenic(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000065666	12	112910827	12	112473023	65666	76574	rs121918456	NC_000012.12:112473022:A:C
NM_002834.4(PTPN11):c.1517_1518delinsCC (p.Gln506Pro)	PTPN11	Q506P, Q510P	Rasopathy	Pathogenic(Last reviewed: Jan 1, 2007)	criteria provided, single submitter	VCV000055799	12	112926897 - 112926898	12	112489093 - 112489094	55799	70455	rs397509345	NC_000012.12:112489092:AG:CC
NM_002834.5(PTPN11):c.855T>G (p.Phe285Leu)	PTPN11	F285L, F284L	not provided|Rasopathy|Noonan syndrome|Noonan syndrome 3	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000044615	12	112915456	12	112477652	44615	53782	rs397516810	NC_000012.12:112477651:T:G
NM_002834.5(PTPN11):c.209A>G (p.Lys70Arg)	PTPN11	K70R, K69R	Noonan syndrome|Rasopathy|not provided	Pathogenic(Last reviewed: Jun 25, 2020)	reviewed by expert panel	VCV000044603	12	112888193	12	112450389	44603	53770	rs397516801	NC_000012.12:112450388:A:G
NM_002834.4(PTPN11):c.1530G>C (p.Gln510His)	PTPN11	Q510H, Q514H	Rasopathy|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040567	12	112926910	12	112489106	40567	49037	rs397507550	NC_000012.12:112489105:G:C
NM_002834.5(PTPN11):c.1528C>G (p.Gln510Glu)	PTPN11	Q510E, Q514E, Q509E	Noonan syndrome 3|LEOPARD syndrome 1|Noonan syndrome|Noonan syndrome with multiple lentigines|Cardiovascular phenotype|Rasopathy|not provided|Noonan syndrome 1	Pathogenic(Last reviewed: Oct 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040566	12	112926908	12	112489104	40566	49036	rs397507549	NC_000012.12:112489103:C:G
NM_002834.5(PTPN11):c.1517A>C (p.Gln506Pro)	PTPN11	Q506P, Q510P, Q505P	Noonan syndrome with multiple lentigines|not provided|Rasopathy|LEOPARD syndrome 1	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040563	12	112926897	12	112489093	40563	49033	rs397507548	NC_000012.12:112489092:A:C
NM_002834.5(PTPN11):c.1510A>G (p.Met504Val)	PTPN11	M504V, M508V, M503V	Noonan syndrome|Rasopathy|Juvenile myelomonocytic leukemia|Noonan syndrome 1|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1|not specified|Inborn genetic diseases|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040562	12	112926890	12	112489086	40562	49032	rs397507547	NC_000012.12:112489085:A:G
NM_002834.5(PTPN11):c.1508G>A (p.Gly503Glu)	PTPN11	G503E, G507E, G502E	not provided|Rasopathy|LEOPARD syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040561	12	112926888	12	112489084	40561	49031	rs397507546	NC_000012.12:112489083:G:A
NM_002834.5(PTPN11):c.1507G>A (p.Gly503Arg)	PTPN11	G503R, G507R, G502R	Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype|Rasopathy|Juvenile myelomonocytic leukemia|Noonan syndrome 1|LEOPARD syndrome 1|Metachondromatosis|Juvenile myelomonocytic leukemia|Noonan syndrome|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040559	12	112926887	12	112489083	40559	49029	rs397507545	NC_000012.12:112489082:G:A
NM_002834.5(PTPN11):c.1507G>C (p.Gly503Arg)	PTPN11	G503R, G507R, G502R	Noonan syndrome|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome 1|LEOPARD syndrome 1|Metachondromatosis|not provided|Juvenile myelomonocytic leukemia|Noonan syndrome|Rasopathy	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040558	12	112926887	12	112489083	40558	49028	rs397507545	NC_000012.12:112489082:G:C
NM_002834.5(PTPN11):c.1505C>T (p.Ser502Leu)	PTPN11	S502L, S506L, S501L	Noonan syndrome|Rasopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040557	12	112926885	12	112489081	40557	49027	rs397507544	NC_000012.12:112489080:C:T
NM_002834.5(PTPN11):c.1502G>A (p.Arg501Lys)	PTPN11	R501K, R505K, R500K	Noonan syndrome|Rasopathy|not provided	Pathogenic(Last reviewed: Jun 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040555	12	112926882	12	112489078	40555	49025	rs397507543	NC_000012.12:112489077:G:A
NM_002834.5(PTPN11):c.1493G>T (p.Arg498Leu)	PTPN11	R498L, R502L, R497L	LEOPARD syndrome 1|Cafe-au-lait spot|Intellectual disability, mild|Scoliosis|Abnormal facial shape|Specific learning disability|Noonan syndrome|Noonan syndrome with multiple lentigines|Rasopathy|not provided|Noonan syndrome 1	Pathogenic(Last reviewed: Nov 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040554	12	112926873	12	112489069	40554	49024	rs397507542	NC_000012.12:112489068:G:T
NM_002834.5(PTPN11):c.1492C>T (p.Arg498Trp)	PTPN11	R498W, R502W, R497W	LEOPARD syndrome 1|Noonan syndrome 1|Cafe-au-lait spot|Axillary freckling|Downslanted palpebral fissures|Short neck|Long philtrum|Noonan syndrome|Noonan syndrome with multiple lentigines|Rasopathy|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040553	12	112926872	12	112489068	40553	49023	rs397507541	NC_000012.12:112489067:C:T
NM_002834.5(PTPN11):c.1472C>T (p.Pro491Leu)	PTPN11	P491L, P495L, P490L	Noonan syndrome 1|Rasopathy|not specified|not provided|Noonan syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040552	12	112926852	12	112489048	40552	49022	rs397507540	NC_000012.12:112489047:C:T
NM_002834.5(PTPN11):c.1471C>T (p.Pro491Ser)	PTPN11	P491S, P495S, P490S	Noonan syndrome|not specified|Rasopathy|Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040550	12	112926851	12	112489047	40550	49020	rs397507539	NC_000012.12:112489046:C:T
NM_002834.5(PTPN11):c.1471C>A (p.Pro491Thr)	PTPN11	P491T, P495T, P490T	Noonan syndrome 1|Rasopathy|not provided|Noonan syndrome	Pathogenic(Last reviewed: Feb 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040549	12	112926851	12	112489047	40549	49019	rs397507539	NC_000012.12:112489046:C:A
NM_002834.5(PTPN11):c.1402A>C (p.Thr468Pro)	PTPN11	T468P, T472P, T467P	Rasopathy|not provided	Pathogenic(Last reviewed: Jun 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040547	12	112926269	12	112488465	40547	49017	rs397507537	NC_000012.12:112488464:A:C
NM_002834.5(PTPN11):c.1381G>T (p.Ala461Ser)	PTPN11	A461S, A465S, A460S	Rasopathy|Noonan syndrome with multiple lentigines|not provided	Pathogenic(Last reviewed: Apr 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040546	12	112926248	12	112488444	40546	49016	rs121918468	NC_000012.12:112488443:G:T
NM_002834.5(PTPN11):c.923A>C (p.Asn308Thr)	PTPN11	N308T, N307T	Noonan syndrome|Rasopathy|not provided	Pathogenic(Last reviewed: Oct 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040535	12	112915524	12	112477720	40535	49005	rs121918455	NC_000012.12:112477719:A:C
NM_002834.5(PTPN11):c.854T>G (p.Phe285Cys)	PTPN11	F285C, F284C	Rasopathy|Noonan syndrome|not provided	Pathogenic(Last reviewed: Feb 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040533	12	112915455	12	112477651	40533	49003	rs121918463	NC_000012.12:112477650:T:G
NM_002834.5(PTPN11):c.853T>C (p.Phe285Leu)	PTPN11	F285L, F284L	Noonan syndrome 3|Noonan syndrome|Rasopathy|Juvenile myelomonocytic leukemia|Noonan syndrome 1|LEOPARD syndrome 1|Metachondromatosis|not provided|Inborn genetic diseases|Noonan syndrome 1	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040528	12	112910844	12	112473040	40528	48998	rs397507531	NC_000012.12:112473039:T:C
NM_002834.5(PTPN11):c.844A>G (p.Ile282Val)	PTPN11	I282V, I281V	Noonan syndrome|Noonan syndrome with multiple lentigines|Rasopathy|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040525	12	112910835	12	112473031	40525	48995	rs397507529	NC_000012.12:112473030:A:G
NM_002834.5(PTPN11):c.802G>T (p.Gly268Cys)	PTPN11	G268C, G267C	Noonan syndrome|Rasopathy|not provided|PTPN11 Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040523	12	112910793	12	112472989	40523	48993	rs397507527	NC_000012.12:112472988:G:T
NM_002834.5(PTPN11):c.794G>A (p.Arg265Gln)	PTPN11	R265Q, R264Q	LEOPARD syndrome 1|Noonan syndrome 1|Rasopathy|Noonan syndrome|Metachondromatosis|not provided|Inborn genetic diseases|PTPN11-related disorder	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040522	12	112910785	12	112472981	40522	48992	rs376607329	NC_000012.12:112472980:G:A
NM_002834.4(PTPN11):c.785T>G (p.Leu262Arg)	PTPN11	L262R	Rasopathy|Noonan syndrome 1	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040521	12	112910776	12	112472972	40521	48991	rs397507526	NC_000012.12:112472971:T:G
NM_002834.5(PTPN11):c.781C>T (p.Leu261Phe)	PTPN11	L261F, L260F	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040520	12	112910772	12	112472968	40520	48990	rs397507525	NC_000012.12:112472967:C:T
NM_002834.5(PTPN11):c.767A>G (p.Gln256Arg)	PTPN11	Q256R, Q255R	not specified|not provided|Noonan syndrome 1|Noonan syndrome|Noonan syndrome with multiple lentigines|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040518	12	112910758	12	112472954	40518	48988	rs397507523	NC_000012.12:112472953:A:G
NM_002834.5(PTPN11):c.417G>C (p.Glu139Asp)	PTPN11	E139D, E138D	Hypertrophic cardiomyopathy|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|not provided|not specified|Global developmental delay|Pectus excavatum|Microcephaly|Ptosis|Brachycephaly|Noonan syndrome 3|Rasopathy|Noonan syndrome|Cardiovascular phenotype|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040513	12	112891083	12	112453279	40513	48983	rs397507520	NC_000012.12:112453278:G:C
NM_002834.5(PTPN11):c.417G>T (p.Glu139Asp)	PTPN11	E139D, E138D	not provided|Rasopathy|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040512	12	112891083	12	112453279	40512	48982	rs397507520	NC_000012.12:112453278:G:T
NM_002834.4(PTPN11):c.329A>C (p.Glu110Ala)	PTPN11	E110A	not specified|Rasopathy|not provided|Noonan syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040508	12	112888313	12	112450509	40508	48978	rs397507519	NC_000012.12:112450508:A:C
NM_002834.5(PTPN11):c.328G>A (p.Glu110Lys)	PTPN11	E110K, E109K	not provided|Noonan syndrome 3|Rasopathy|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040507	12	112888312	12	112450508	40507	48977	rs397507518	NC_000012.12:112450507:G:A
NM_002834.5(PTPN11):c.317A>C (p.Asp106Ala)	PTPN11	D106A, D105A	not provided|Rasopathy|Noonan syndrome 1|Noonan syndrome	Pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040506	12	112888301	12	112450497	40506	48976	rs397507517	NC_000012.12:112450496:A:C
NM_002834.5(PTPN11):c.228G>C (p.Glu76Asp)	PTPN11	E76D, E75D	Rasopathy|not provided|Noonan syndrome|Noonan syndrome 1	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040503	12	112888212	12	112450408	40503	48973	rs397507514	NC_000012.12:112450407:G:C
NM_002834.5(PTPN11):c.228G>T (p.Glu76Asp)	PTPN11	E76D, E75D	not provided|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Aug 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040502	12	112888212	12	112450408	40502	48972	rs397507514	NC_000012.12:112450407:G:T
NM_002834.5(PTPN11):c.211T>C (p.Phe71Leu)	PTPN11	F71L, F70L	not provided|Noonan syndrome|Rasopathy|Noonan syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Jun 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040499	12	112888195	12	112450391	40499	48969	rs397507512	NC_000012.12:112450390:T:C
NM_002834.5(PTPN11):c.205G>C (p.Glu69Gln)	PTPN11	E69Q, E68Q	Rasopathy|not provided|Noonan syndrome	Pathogenic(Last reviewed: Dec 5, 2019)	reviewed by expert panel	VCV000040498	12	112888189	12	112450385	40498	48968	rs397507511	NC_000012.12:112450384:G:C
NM_002834.4(PTPN11):c.182A>T (p.Asp61Val)	PTPN11	D61V	Rasopathy	Pathogenic(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000040496	12	112888166	12	112450362	40496	48966	rs121918461	NC_000012.12:112450361:A:T
NM_002834.5(PTPN11):c.181G>A (p.Asp61Asn)	PTPN11	D61N, D60N	not provided|LEOPARD syndrome 1|Noonan syndrome 1|Noonan syndrome|Rasopathy|Noonan syndrome 3	Pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040495	12	112888165	12	112450361	40495	48965	rs397507510	NC_000012.12:112450360:G:A
NM_002834.4(PTPN11):c.181G>C (p.Asp61His)	PTPN11	D61H	not provided|Noonan syndrome 3	Pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040494	12	112888165	12	112450361	40494	48964	rs397507510	NC_000012.12:112450360:G:C
NM_002834.5(PTPN11):c.179G>C (p.Gly60Ala)	PTPN11	G60A, G59A	Noonan syndrome|not provided|Rasopathy|Noonan syndrome 1	Pathogenic(Last reviewed: Jul 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040493	12	112888163	12	112450359	40493	48963	rs397507509	NC_000012.12:112450358:G:C
NM_002834.5(PTPN11):c.178G>A (p.Gly60Ser)	PTPN11	G60S, G59S	not provided|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: May 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040490	12	112888162	12	112450358	40490	48960	rs397507507	NC_000012.12:112450357:G:A
NM_002834.5(PTPN11):c.174C>G (p.Asn58Lys)	PTPN11	N58K, N57K	Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|not provided|Rasopathy|Noonan syndrome|Noonan syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Feb 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040489	12	112888158	12	112450354	40489	48959	rs397507506	NC_000012.12:112450353:C:G
NM_002834.5(PTPN11):c.174C>A (p.Asn58Lys)	PTPN11	N58K, N57K	not provided|Noonan syndrome 3|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040488	12	112888158	12	112450354	40488	48958	rs397507506	NC_000012.12:112450353:C:A
NM_002834.5(PTPN11):c.172A>G (p.Asn58Asp)	PTPN11	N58D, N57D	Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome 1|Metachondromatosis|not provided|Noonan syndrome|Rasopathy	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040487	12	112888156	12	112450352	40487	48957	rs397507505	NC_000012.12:112450351:A:G
NM_002834.5(PTPN11):c.172A>C (p.Asn58His)	PTPN11	N58H, N57H	Rasopathy|Noonan syndrome|not provided	Pathogenic(Last reviewed: Dec 4, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040486	12	112888156	12	112450352	40486	48956	rs397507505	NC_000012.12:112450351:A:C
NM_002834.5(PTPN11):c.166A>G (p.Ile56Val)	PTPN11	I56V, I55V	not provided|Noonan syndrome and Noonan-related syndrome|Rasopathy|Noonan syndrome 1|Noonan syndrome	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040485	12	112888150	12	112450346	40485	48955	rs397507504	NC_000012.12:112450345:A:G
NM_002834.5(PTPN11):c.124A>G (p.Thr42Ala)	PTPN11	T42A	not provided|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040482	12	112884189	12	112446385	40482	48952	rs397507501	NC_000012.12:112446384:A:G
NM_002834.5(PTPN11):c.5C>T (p.Thr2Ile)	PTPN11	T2I	Noonan syndrome|Metachondromatosis|Rasopathy|not provided|Noonan syndrome 1	Pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013349	12	112856920	12	112419116	13349	28388	rs267606990	NC_000012.12:112419115:C:T
NM_002834.4(PTPN11):c.1529A>G (p.Gln510Arg)	PTPN11	Q510R, Q514R	not provided|Rasopathy|Noonan syndrome 1|LEOPARD syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013345	12	112926909	12	112489105	13345	28384	rs121918470	NC_000012.12:112489104:A:G
NM_002834.5(PTPN11):c.1529A>C (p.Gln510Pro)	PTPN11	Q510P, Q514P, Q509P	Noonan syndrome 1|Noonan syndrome with multiple lentigines|Rasopathy|Noonan syndrome 3|LEOPARD syndrome 1|not provided|Noonan syndrome with multiple lentigines|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013344	12	112926909	12	112489105	13344	28383	rs121918470	NC_000012.12:112489104:A:C
NM_002834.5(PTPN11):c.1391G>C (p.Gly464Ala)	PTPN11	G464A, G468A, G463A	Rasopathy|not provided|LEOPARD syndrome 1|Noonan syndrome with multiple lentigines|Noonan syndrome	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013343	12	112926258	12	112488454	13343	28382	rs121918469	NC_000012.12:112488453:G:C
NM_002834.5(PTPN11):c.1381G>A (p.Ala461Thr)	PTPN11	A461T, A465T, A460T	Noonan syndrome with multiple lentigines|Rasopathy|not specified|LEOPARD syndrome 1|Noonan syndrome 1|not provided	Pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013342	12	112926248	12	112488444	13342	28381	rs121918468	NC_000012.12:112488443:G:A
NM_002834.5(PTPN11):c.236A>G (p.Gln79Arg)	PTPN11	Q79R, Q78R	Rasopathy|Noonan syndrome|Noonan syndrome 3|not provided|Noonan syndrome 1|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1	Pathogenic(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013340	12	112888220	12	112450416	13340	28379	rs121918466	NC_000012.12:112450415:A:G
NM_002834.4(PTPN11):c.227A>C (p.Glu76Ala)	PTPN11	E76A	Astrocytoma|Juvenile myelomonocytic leukemia|Neoplasm of the large intestine|Neuroblastoma|Multiple myeloma|Squamous cell lung carcinoma|not provided	Pathogenic(Last reviewed: Sep 27, 2016)	criteria provided, single submitter	VCV000013339	12	112888211	12	112450407	13339	28378	rs121918465	NC_000012.12:112450406:A:C
NM_002834.4(PTPN11):c.227A>T (p.Glu76Val)	PTPN11	E76V	Juvenile myelomonocytic leukemia|not provided|Rasopathy	Pathogenic(Last reviewed: Dec 10, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013337	12	112888211	12	112450407	13337	28376	rs121918465	NC_000012.12:112450406:A:T
NM_002834.4(PTPN11):c.226G>A (p.Glu76Lys)	PTPN11	E76K	Astrocytoma|Rasopathy|Noonan syndrome|Neoplasm of the large intestine|Neuroblastoma|Multiple myeloma|Squamous cell lung carcinoma|Cancer|not provided|Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013336	12	112888210	12	112450406	13336	28375	rs121918464	NC_000012.12:112450405:G:A
NM_002834.5(PTPN11):c.854T>C (p.Phe285Ser)	PTPN11	F285S, F284S	Noonan syndrome 1|Rasopathy|Noonan syndrome|not provided|Early T cell progenitor acute lymphoblastic leukemia	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013335	12	112915455	12	112477651	13335	28374	rs121918463	NC_000012.12:112477650:T:C
NM_002834.5(PTPN11):c.218C>T (p.Thr73Ile)	PTPN11	T73I, T72I	Rasopathy|Noonan syndrome|not provided|Noonan syndrome 1|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1	Pathogenic(Last reviewed: Apr 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013334	12	112888202	12	112450398	13334	28373	rs121918462	NC_000012.12:112450397:C:T
NM_002834.5(PTPN11):c.188A>G (p.Tyr63Cys)	PTPN11	Y63C, Y62C	Noonan syndrome|not provided|Noonan syndrome 1|B lymphoblastic leukemia lymphoma, no ICD-O subtype|Lymphoma|Rasopathy|Noonan syndrome 3|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013333	12	112888172	12	112450368	13333	28372	rs121918459	NC_000012.12:112450367:A:G
NM_002834.5(PTPN11):c.1403C>T (p.Thr468Met)	PTPN11	T468M, T472M, T467M	Rasopathy|Noonan syndrome with multiple lentigines|not provided|PTPN11-related disorder|LEOPARD syndrome 1|Noonan syndrome 1|Noonan syndrome|not specified|Inborn genetic diseases|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013331	12	112926270	12	112488466	13331	28370	rs121918457	NC_000012.12:112488465:C:T
NM_002834.5(PTPN11):c.182A>G (p.Asp61Gly)	PTPN11	D61G, D60G	Rasopathy|Noonan syndrome|not provided|Noonan syndrome 1|Juvenile myelomonocytic leukemia|Noonan syndrome|Short stature|Abnormality of cardiovascular system morphology	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013330	12	112888166	12	112450362	13330	28369	rs121918461	NC_000012.12:112450361:A:G
NM_002834.5(PTPN11):c.184T>G (p.Tyr62Asp)	PTPN11	Y62D, Y61D	not provided|Rasopathy|Inborn genetic diseases|Noonan syndrome|Juvenile myelomonocytic leukemia|Noonan syndrome|Noonan syndrome 1|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1|Dysplastic pulmonary valve|Right ventricular hypertrophy|Secundum atrial septal defect|Tricuspid regurgitation|Failure to thrive|Patent ductus arteriosus	Pathogenic(Last reviewed: Feb 14, 2020)	reviewed by expert panel	VCV000013329	12	112888168	12	112450364	13329	28368	rs121918460	NC_000012.12:112450363:T:G
NM_002834.5(PTPN11):c.836A>G (p.Tyr279Cys)	PTPN11	Y279C, Y278C	Hypertelorism|Multiple lentigines|Severe short stature|Abnormality of the mitral valve|Small face|Short neck|Scapular winging|Anteverted nares|Arachnoid cyst|Bilateral sensorineural hearing impairment|Cardiovascular phenotype|Noonan syndrome with multiple lentigines|Rasopathy|not specified|Noonan syndrome 1|Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Noonan syndrome with multiple lentigines|Noonan syndrome|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013328	12	112910827	12	112473023	13328	28367	rs121918456	NC_000012.12:112473022:A:G
NM_002834.5(PTPN11):c.923A>G (p.Asn308Ser)	PTPN11	N308S, N307S	Noonan syndrome 1|Polymalformative syndrome|Rasopathy|LEOPARD syndrome 1|Noonan syndrome 1|Noonan syndrome 3|Noonan syndrome|PTPN11 Related Disorders|not provided|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1|not specified	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013327	12	112915524	12	112477720	13327	28366	rs121918455	NC_000012.12:112477719:A:G
NM_002834.5(PTPN11):c.922A>G (p.Asn308Asp)	PTPN11	N308D, N307D	Cardiovascular phenotype|Rasopathy|Noonan syndrome|not specified|LEOPARD syndrome 1|Noonan syndrome 1|Rare genetic syndrome|Noonan syndrome 1|not provided|LEOPARD syndrome 1|Inborn genetic diseases|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013326	12	112915523	12	112477719	13326	28365	rs28933386	NC_000012.12:112477718:A:G
NM_002834.5(PTPN11):c.215C>G (p.Ala72Gly)	PTPN11	A72G, A71G	Noonan syndrome|not provided|Rasopathy|Noonan syndrome 3|Noonan syndrome 1|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013325	12	112888199	12	112450395	13325	28364	rs121918454	NC_000012.12:112450394:C:G
NM_002834.5(PTPN11):c.214G>T (p.Ala72Ser)	PTPN11	A72S, A71S	Rasopathy|not provided|LEOPARD syndrome 1|Noonan syndrome 1|Noonan syndrome 1|Noonan syndrome|Juvenile myelomonocytic leukemia|LEOPARD syndrome 1|Metachondromatosis|Noonan syndrome 1	Pathogenic(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013324	12	112888198	12	112450394	13324	28363	rs121918453	NC_000012.12:112450393:G:T
NM_001354689.3(RAF1):c.775T>G (p.Ser259Ala)	RAF1	S259A, S226A, S178A, S145A	not provided|Rasopathy|not specified	Pathogenic(Last reviewed: Jun 25, 2020)	reviewed by expert panel	VCV000504514	3	12645694	3	12604195	504514	496336	rs3730271	NC_000003.12:12604194:A:C
NM_001354689.3(RAF1):c.782C>T (p.Pro261Leu)	RAF1	P261L, P180L, P228L, P147L	not provided|Noonan syndrome 5|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000120246	3	12645687	3	12604188	120246	125840	rs397516828	NC_000003.12:12604187:G:A
NM_001354689.3(RAF1):c.776C>A (p.Ser259Tyr)	RAF1	S259Y, S226Y, S145Y, S178Y	not specified|Rasopathy|Noonan syndrome|LEOPARD syndrome 2	Pathogenic(Last reviewed: May 18, 2020)	reviewed by expert panel	VCV000044633	3	12645693	3	12604194	44633	53800	rs397516827	NC_000003.12:12604193:G:T
NM_001354689.3(RAF1):c.766A>G (p.Arg256Gly)	RAF1	R256G, R142G, R175G, R223G	Noonan syndrome|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000044631	3	12645703	3	12604204	44631	53798	rs397516825	NC_000003.12:12604203:T:C
NM_001354689.3(RAF1):c.1517A>G (p.Asp506Gly)	RAF1	D486G, D506G, D405G, D425G, D372G, D453G	Noonan syndrome|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040618	3	12627259	3	12585760	40618	49088	rs397516815	NC_000003.12:12585759:T:C
NM_001354689.3(RAF1):c.1142G>C (p.Gly381Ala)	RAF1	G361A, G381A, G247A, G280A, G328A, G300A	Noonan syndrome|not provided|Rasopathy|LEOPARD syndrome 2	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040613	3	12641216	3	12599717	40613	49083	rs397516813	NC_000003.12:12599716:C:G
NM_001354689.3(RAF1):c.788T>C (p.Val263Ala)	RAF1	V263A, V182A, V149A, V230A	Rasopathy|not provided|Noonan syndrome	Pathogenic(Last reviewed: Jun 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040608	3	12645681	3	12604182	40608	49078	rs397516830	NC_000003.12:12604181:A:G
NM_001354689.3(RAF1):c.782C>G (p.Pro261Arg)	RAF1	P261R, P147R, P180R, P228R	Noonan syndrome|not provided|Noonan syndrome 5|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000040606	3	12645687	3	12604188	40606	49076	rs397516828	NC_000003.12:12604187:G:C
NM_001354689.3(RAF1):c.781C>G (p.Pro261Ala)	RAF1	P261A, P180A, P147A, P228A	Noonan syndrome|Rasopathy|Primary familial hypertrophic cardiomyopathy|not provided|LEOPARD syndrome 2|Noonan syndrome 5|Cardiomyopathy, dilated, 1NN	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040605	3	12645688	3	12604189	40605	49075	rs121434594	NC_000003.12:12604188:G:C
NM_001354689.3(RAF1):c.781C>A (p.Pro261Thr)	RAF1	P261T, P147T, P180T, P228T	Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040604	3	12645688	3	12604189	40604	49074	rs121434594	NC_000003.12:12604188:G:T
NM_001354689.3(RAF1):c.776C>T (p.Ser259Phe)	RAF1	S259F, S226F, S145F, S178F	Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Jul 8, 2015)	criteria provided, single submitter	VCV000040603	3	12645693	3	12604194	40603	49073	rs397516827	NC_000003.12:12604193:G:A
NM_001354689.3(RAF1):c.776C>G (p.Ser259Cys)	RAF1	S259C, S178C, S145C, S226C	Rasopathy|not provided|Noonan syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040602	3	12645693	3	12604194	40602	49072	rs397516827	NC_000003.12:12604193:G:C
NM_001354689.3(RAF1):c.775T>A (p.Ser259Thr)	RAF1	S259T, S145T, S178T, S226T	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040601	3	12645694	3	12604195	40601	49071	rs3730271	NC_000003.12:12604194:A:T
NM_001354689.3(RAF1):c.768G>T (p.Arg256Ser)	RAF1	R256S, R142S, R223S, R175S	Rasopathy|not provided|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040599	3	12645701	3	12604202	40599	49069	rs397516826	NC_000003.12:12604201:C:A
NM_001354689.3(RAF1):c.1532C>T (p.Thr511Ile)	RAF1	T491I, T511I, T430I, T410I, T458I, T377I	Noonan syndrome with multiple lentigines|Rasopathy|Noonan syndrome|not provided|Cardiovascular phenotype	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000021342	3	12627244	3	12585745	21342	34194	rs80338799	NC_000003.12:12585744:G:A
NM_001354689.3(RAF1):c.1897C>G (p.Leu633Val)	RAF1	L613V, L633V, L499V, L580V, L552V, L532V	LEOPARD syndrome 2|Noonan syndrome 5|Noonan syndrome with multiple lentigines|Noonan syndrome|not provided|Familial hypertrophic cardiomyopathy 1|Rasopathy|Noonan syndrome|Noonan syndrome with multiple lentigines	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013960	3	12626123	3	12584624	13960	28999	rs80338797	NC_000003.12:12584623:G:C
NM_001354689.3(RAF1):c.781C>T (p.Pro261Ser)	RAF1	P261S, P180S, P147S, P228S	Cardiovascular phenotype|Inborn genetic diseases|Noonan syndrome 5|Primary familial hypertrophic cardiomyopathy|Rasopathy|Noonan syndrome|not provided	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013958	3	12645688	3	12604189	13958	28997	rs121434594	NC_000003.12:12604188:G:A
NM_001354689.3(RAF1):c.770C>T (p.Ser257Leu)	RAF1	S257L, S224L, S143L, S176L	Noonan syndrome|Hypertrophic cardiomyopathy|Long philtrum|Single transverse palmar crease|Short neck|Wide nasal bridge|Congenital ptosis|Craniofacial disproportion|Pulmonic stenosis (disease)|Epicanthus|High palate|Downslanted palpebral fissures|Low-set ears|Polyhydramnios|Neonatal hypotonia|Atrial septal defect|Patent ductus arteriosus after birth at term|Unilateral ptosis|Noonan syndrome 5|LEOPARD syndrome 2|Malignant melanoma of skin|Neoplasm of the large intestine|Noonan syndrome with multiple lentigines|Rasopathy|Cardiomyopathy, dilated, 1NN|Noonan syndrome 5|LEOPARD syndrome 2|Noonan syndrome 1|Inborn genetic diseases|not provided|Adenocarcinoma of stomach|Noonan syndrome with multiple lentigines|Noonan syndrome|Lung adenocarcinoma	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013957	3	12645699	3	12604200	13957	28996	rs80338796	NC_000003.12:12604199:G:A
NM_006912.6(RIT1):c.268A>G (p.Met90Val)	RIT1	M90V, M107V, M54V	Noonan syndrome|Rasopathy|Noonan syndrome 8|not provided	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000561681	1	155874263	1	155904472	561681	552492	rs1557960039	NC_000001.11:155904471:T:C
NM_006912.6(RIT1):c.247A>C (p.Thr83Pro)	RIT1	T83P, T100P, T47P	Noonan syndrome 1|not provided|Rasopathy|Noonan syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183409	1	155874284	1	155904493	183409	181507	rs869025195	NC_000001.11:155904492:T:G
NM_006912.6(RIT1):c.242A>G (p.Glu81Gly)	RIT1	E81G, E98G, E45G	Rasopathy|not provided|Inborn genetic diseases|Noonan syndrome|Noonan syndrome 8|not specified	Pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183405	1	155874289	1	155904498	183405	181511	rs869025193	NC_000001.11:155904497:T:C
NM_006912.6(RIT1):c.246T>G (p.Phe82Leu)	RIT1	F82L, F99L, F46L	Rasopathy|not provided|Noonan syndrome 8|Noonan syndrome	Pathogenic(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181522	1	155874285	1	155904494	181522	178911	rs730881014	NC_000001.11:155904493:A:C
NM_006912.6(RIT1):c.284G>C (p.Gly95Ala)	RIT1	G95A, G112A, G59A	Noonan syndrome|Noonan syndrome 8|Rasopathy|not provided	Pathogenic(Last reviewed: Nov 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000060509	1	155874247	1	155904456	60509	75096	rs672601335	NC_000001.11:155904455:C:G
NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly)	SHOC2	S2G	Rasopathy|not provided|Noonan syndrome|Inborn genetic diseases|not specified|Noonan syndrome-like disorder with loose anagen hair|Noonan syndrome-like disorder with loose anagen hair 1|Relative macrocephaly|Abnormality of the sternum|Short stature	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000006821	10	112724120	10	110964362	6821	21860	rs267607048	NC_000010.11:110964361:A:G
NM_005633.3(SOS1):c.1310T>C (p.Ile437Thr)	SOS1	I437T	Rasopathy|Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045345	2	39250259	2	39023118	45345	54512	rs397517150	NC_000002.12:39023117:A:G
NM_005633.3(SOS1):c.1132A>G (p.Thr378Ala)	SOS1	T378A	Rasopathy|not provided|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045344	2	39251221	2	39024080	45344	54511	rs397517146	NC_000002.12:39024079:T:C
NM_005633.3(SOS1):c.2536G>A (p.Glu846Lys)	SOS1	E846K	Rasopathy|Noonan syndrome|not provided|Noonan syndrome 4|Gingival fibromatosis 1	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040706	2	39234309	2	39007168	40706	49176	rs397517159	NC_000002.12:39007167:C:T
NM_005633.3(SOS1):c.2197A>T (p.Ile733Phe)	SOS1	I733F	Noonan syndrome 3|not provided|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Aug 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040701	2	39239460	2	39012319	40701	49171	rs574088829	NC_000002.12:39012318:T:A
NM_005633.3(SOS1):c.2183A>T (p.Lys728Ile)	SOS1	K728I	Rasopathy|Noonan syndrome 4|Noonan syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040699	2	39239474	2	39012333	40699	49169	rs397517156	NC_000002.12:39012332:T:A
NM_005633.3(SOS1):c.2104T>C (p.Tyr702His)	SOS1	Y702H	Noonan syndrome|Rasopathy|not provided	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040696	2	39240664	2	39013523	40696	49166	rs727505381	NC_000002.12:39013522:A:G
NM_005633.3(SOS1):c.1656G>T (p.Arg552Ser)	SOS1	R552S	Rasopathy|Noonan syndrome|Noonan syndrome 4|Gingival fibromatosis 1|not provided|Noonan syndrome and Noonan-related syndrome	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040684	2	39249913	2	39022772	40684	49154	rs267607079	NC_000002.12:39022771:C:A
NM_005633.3(SOS1):c.1655G>A (p.Arg552Lys)	SOS1	R552K	Rasopathy|Noonan syndrome 1|Noonan syndrome 4|Noonan syndrome|not provided|Noonan syndrome 3	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040683	2	39249914	2	39022773	40683	49153	rs397517154	NC_000002.12:39022772:C:T
NM_005633.3(SOS1):c.1655G>C (p.Arg552Thr)	SOS1	R552T	Rasopathy|not provided|Abnormality of the aortic valve|Noonan syndrome	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000040682	2	39249914	2	39022773	40682	49152	rs397517154	NC_000002.12:39022772:C:G
NM_005633.3(SOS1):c.1649T>C (p.Leu550Pro)	SOS1	L550P	Rasopathy|not provided|Noonan syndrome	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040680	2	39249920	2	39022779	40680	49150	rs397517153	NC_000002.12:39022778:A:G
NM_005633.3(SOS1):c.1642A>C (p.Ser548Arg)	SOS1	S548R	Rasopathy|not provided|Inborn genetic diseases|Gingival fibromatosis 1|Noonan syndrome 4|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040678	2	39249927	2	39022786	40678	49148	rs397517149	NC_000002.12:39022785:T:G
NM_005633.3(SOS1):c.1322G>A (p.Cys441Tyr)	SOS1	C441Y	not provided|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040673	2	39250247	2	39023106	40673	49143	rs727504295	NC_000002.12:39023105:C:T
NM_005633.3(SOS1):c.1300G>A (p.Gly434Arg)	SOS1	G434R	Rasopathy|not provided|Short stature|Ptosis|Abnormality of the sternum|Pulmonic stenosis (disease)|Noonan syndrome 1|Noonan syndrome	Pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040672	2	39250269	2	39023128	40672	49142	rs397517148	NC_000002.12:39023127:C:T
NM_005633.3(SOS1):c.1300_1301delinsAA (p.Gly434Lys)	SOS1	G434K	Rasopathy	Pathogenic(Last reviewed: Jun 1, 2012)	criteria provided, single submitter	VCV000040671	2	39250268 - 39250269	2	39023127 - 39023128	40671	49141	rs730881048	NC_000002.12:39023126:CC:TT
NM_005633.3(SOS1):c.1300G>C (p.Gly434Arg)	SOS1	G434R	Rasopathy|not specified	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040670	2	39250269	2	39023128	40670	49140	rs397517148	NC_000002.12:39023127:C:G
NM_005633.3(SOS1):c.1297G>A (p.Glu433Lys)	SOS1	E433K	Noonan syndrome|not provided|Rasopathy	Pathogenic(Last reviewed: Oct 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040669	2	39250272	2	39023131	40669	49139	rs397517147	NC_000002.12:39023130:C:T
NM_005633.3(SOS1):c.806T>C (p.Met269Thr)	SOS1	M269T	Rasopathy|not provided|Noonan syndrome|Noonan syndrome 4|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040662	2	39278343	2	39051202	40662	49132	rs137852813	NC_000002.12:39051201:A:G
NM_005633.3(SOS1):c.508A>G (p.Lys170Glu)	SOS1	K170E	Inborn genetic diseases|Noonan syndrome|not specified|not provided|Rasopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040651	2	39283845	2	39056704	40651	49121	rs397517172	NC_000002.12:39056703:T:C
NM_005633.3(SOS1):c.322G>A (p.Glu108Lys)	SOS1	E108K	Rasopathy|not provided|Noonan syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040649	2	39285837	2	39058696	40649	49119	rs397517164	NC_000002.12:39058695:C:T
NM_005633.3(SOS1):c.1294T>C (p.Trp432Arg)	SOS1	W432R	Rasopathy|Noonan syndrome|not provided|Noonan syndrome 4	Pathogenic(Last reviewed: Nov 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012873	2	39250275	2	39023134	12873	27912	rs267607080	NC_000002.12:39023133:A:G
NM_005633.3(SOS1):c.1656G>C (p.Arg552Ser)	SOS1	R552S	Gingival fibromatosis 1|Noonan syndrome 4|Noonan syndrome|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 4|not provided|Rasopathy|Noonan syndrome 1	Pathogenic(Last reviewed: May 10, 2019)	reviewed by expert panel	VCV000012872	2	39249913	2	39022772	12872	27911	rs267607079	NC_000002.12:39022771:C:G
NM_005633.3(SOS1):c.1654A>G (p.Arg552Gly)	SOS1	R552G	Noonan syndrome|not provided|Rasopathy|Gingival fibromatosis 1|Noonan syndrome 4|Noonan syndrome 4	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012871	2	39249915	2	39022774	12871	27910	rs137852814	NC_000002.12:39022773:T:C
NM_005633.3(SOS1):c.806T>G (p.Met269Arg)	SOS1	M269R	Noonan syndrome|not provided|Noonan syndrome 1|Noonan syndrome 4|Rasopathy	Pathogenic(Last reviewed: Aug 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012870	2	39278343	2	39051202	12870	27909	rs137852813	NC_000002.12:39051201:A:C
NM_005633.3(SOS1):c.797C>A (p.Thr266Lys)	SOS1	T266K	Gingival fibromatosis 1|Noonan syndrome 4|Noonan syndrome|Noonan syndrome 4|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012869	2	39278352	2	39051211	12869	27908	rs137852812	NC_000002.12:39051210:G:T
NM_006939.4(SOS2):c.791C>A (p.Thr264Lys)	SOS2	T264K	Noonan syndrome|Rasopathy|Noonan syndrome 9	Pathogenic/Likely pathogenic(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000684626	14	50649248	14	50182530	684626	672277	rs1595001710	NC_000014.9:50182529:G:T
NM_006939.4(SOS2):c.800T>G (p.Met267Arg)	SOS2	M267R	Noonan syndrome 9|Aortic aneurysm|Abnormal aortic morphology|Ventricular septal defect|Joint laxity|Abnormality of the mitral valve|Heterochromia iridis|EMG abnormality|Predominantly lower limb lymphedema|Lymphedema|Sensorimotor neuropathy|Muscle weakness|Peripheral axonal neuropathy|Noonan syndrome|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000577079	14	50649239	14	50182521	577079	566487	rs797045167	NC_000014.9:50182520:A:C
